US Oncology Affiliated Physicians Make a Strong Showing in ASCO P...(d hyperlipidemia in patients with...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
US Oncology Affiliated Physicians Make a Strong Showing in ASCO Proceedings
Date:6/2/2008
d
hyperlipidemia in patients with advanced renal cell carcinoma
treated with temsirolimus or interferon
Gynecologic
-- Michael Teneriello, M.D., Texas Oncology-Austin Central, co-chair,
US Oncology Gynecologic Cancer Research Committee: Phase III trial of
induction gemcitabine (G) or paclitaxel (T) plus carboplatin (C)
followed by elective T consolidation in advanced ovarian cancer (OC):
Interim analysis of induction chemotherapy
Melanoma
-- William Stephenson, M.D., Kansas City Cancer Center-South: PhaseI/II
study of imexon (AMP) plus dacarbazine (DTIC) in patients (Pts) with
metastatic malignant melanoma
Leukemia
-- Roger Lyons, M.D., Cancer Care Centers of South Texas-Medical Center:
Phase II study of single agent clofarabine in previously untreated
older adult patients with acute myelogenous leukemia (AML) unlikely to
benefit from standard induction chemotherapy
Solid Tumors
-- William Stephenson, M.D., Kansas City Cancer Center-South: Phase I
study multicenter study to assess the safety, tolerability, and
pharmacokinetics of AZD4877 administered twice weekly in adult
patients with advanced solid malignancies
-- Robert Raju, M.D., Dayton Oncology & Hematology-Kettering: An open
label Phase I dose escalation study of ADH-1 in combination with
chemotherapy in subjects with N-Cadherin expressing solid tumors
Lymphoma and Plasma Cell Disorders
-- Alan Feiner, M.D., Rocky Mountain Cancer Centers-Rose, and John
Mattern, D.O., Virginia Oncology Associates-Newport News: Primary
therapy of Waldenstrom's macroglobulinemia with bortezomib,
dexamethasone and rituximab: results of WMCTG Clinical Trial 05-180
About US Oncology Research
The US Oncology Research network is an established communit
'/>"/>
| SOURCE US Oncology, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine technology :
1. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
2. New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting
3. Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting
4. BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
5. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
6. Two DOXIL(R) Studies to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
7. Cell Therapeutics, Inc. (CTI) Announces Presentations at American Society of Clinical Oncology (ASCO) Annual Meeting
8. Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting
9. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
10. Genta Clinical Programs Featured in Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
11. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
Post Your Comments:
Breaking Medicine Technology:New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults 2TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting 2Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 2Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 3Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 4Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 5Light at the speed of a bicycle and much more 56500 1Light at the speed of a bicycle and much more 56500 2Sinapis Pharma Announces Frederick Frank as Consultant 56499 1Sinapis Pharma Announces Frederick Frank as Consultant 56499 2Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 1Care Tech Laboratories Agrees to Stop Making Selling and Distributing Unapproved Antimicrobial Products 56497 2
[1] New Research Shows a Vitamin/Nutriceutical Formulation Improves Memory and Cognitive Performance in Community-Dwelling Adults[0] TaiGen Biotechnology Reports Phase I and Preclinical Data for TG-0054 at the 2009 American Society of Hematology (ASH) Annual Meeting[0] Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine
Other Medicine Technology:Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 2Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 3Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 4Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 5Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 6Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 7Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 8Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer 9Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 2Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 3Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 4Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting 5
Breaking Medicine News(10 mins):Health News:Senator Ben Nelson Puts U.S. Bishops' Interests Ahead of Americans' Healthcare Needs 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:Pitt study suggests craving hinders comprehension without your realizing it 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:Wellness Cruise Offers Crystal Guests 'Indian Ocean Insight' 2
[1] Senator Ben Nelson Puts U.S. Bishops' Interests Ahead of Americans' Healthcare Needs[1] Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765[0] Pitt study suggests craving hinders comprehension without your realizing it[0] City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans[1] Wellness Cruise Offers Crystal Guests 'Indian Ocean Insight'
Other Medicine News:Health News:Stem Cells From Hair Follicle To Repair Nerve Damage 2Health News:Credentials Of Specialists Need To Be Checked 2Health News:Calcium From Food Better Than From Supplements 2
Pak Ban On Poultry Imports From 17 CountriesStem Cells From Hair Follicle To Repair Nerve DamageCredentials Of Specialists Need To Be CheckedCalcium From Food Better Than From Supplements Cervical Cancer Recurrence Risk Even After Removal Of Pre-Cancerous Cells Aged People are at increased risk of disease
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |